Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system)

8 About this resource

The NICE Health Technologies Adoption Programme produces practical advice on adopting health technologies in the NHS in England.

NICE's Health Technologies Adoption Programme worked with NHS organisations to collect and share their experiences of using CoaguChek XS for self-monitoring coagulation status with other organisations that may want to start using this technology in the future. The information gained from these NHS organisations and included in this resource is intended for the sole purpose of supporting the NHS in adopting or further researching point-of-care coagulometers for self-monitoring coagulation status. The information has not been assessed by the independent External Assessment Group or considered by the Diagnostic Assessment Committee when making its decision on the use of point-of-care coagulometers for self-monitoring coagulation status in the NHS.

This resource accompanies NICE's diagnostics guidance on atrial fibrillation and heart valve disease: self‑monitoring coagulation status using point-of-care coagulometers. It was developed using the NICE Health Technologies Adoption Programme process. It is an implementation tool and discusses and summarises the experiences reported by NHS sites who have previously adopted this technology and shares the learning that took place.

Implementation of the guidance is the responsibility of local commissioners and/or providers. Commissioners and providers are reminded that it is their responsibility to implement the guidance, in their local context, in light of their duties to have due regard to the need to eliminate unlawful discrimination, advance equality of opportunity and foster good relations. Nothing in this document should be interpreted in a way that would be inconsistent with compliance with those duties.

More information about the Health Technology Adoption Programme.